Business Wire

PTC

18.10.2018 12:02:07 CEST | Business Wire | Press release

Share
New Industry Research Shows Augmented Reality Adopters Have Best-in-Class Performance Related to Factory Operations, Service, and Training

PTC (NASDAQ: PTC) today announced from Augmented World Expo (AWE) Europe 2018 the availability of new research in conjunction with Aberdeen Group titled, “How the Best-in-Class Use Augmented Reality for Superior Service Management.” The comprehensive research study and corresponding report identifies significant financial improvements realized by industrial companies embracing augmented reality (AR), and provides best practices for unlocking the potential of the technology across various environments.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181018005051/en/

In addition to the report published today, PTC announced exclusive data from Aberdeen that shows that organizations using AR have experienced significant year-over-year business growth and have improved their bottom lines dramatically.

“The rapid pace of the global market, digital transformation, and increasing shortage of highly skilled workers have produced a disruptive threat for businesses,” said Tom Paquin, research analyst, Aberdeen Group. “However, as evidenced by our latest report with PTC, companies that invest in AR, particularly manufacturing and service organizations, have the opportunity to gain a competitive advantage.”

For enterprises, AR can empower workers to understand and interact with the physical and digital worlds, build new skills with reduced training time and cost, and make informed decisions faster. As a result, businesses can unlock increased productivity and improve the effectiveness of training, manufacturing, and service.

“AR is one of the fastest growing segments in the technology market and has been shown to create significant business value for organizations adopting it. Industrial enterprises are keen to improve customer experiences, open up new revenue streams, and disrupt competition by leveraging the new AR capabilities for product and service differentiation,” said Jim Heppelmann, president and CEO, PTC. “Use cases being developed for end customers have a strong focus on service or maintenance instructions, enabling them to reduce machine downtime and maximize product value.”

AWE Europe 2018
PTC and the topic of enterprise AR took center stage today at AWE Europe 2018, the world’s leading AR and VR conference and expo, held October 18-19 in Munich, Germany.

This morning, Mike Campbell, EVP, Augmented Reality Products, PTC, led a keynote session titled, “PTC Vision for Augmented Reality in the Enterprise ,” in which he spoke about the state of AR in the industrial enterprise, reviewed customer use cases, and illustrated the power of AR to fundamentally change the way people work and to allow organizations to re-imagine how to manufacture, sell, operate, and service industrial products.

“Augmented reality can deliver a significant advantage for industrial organizations as part of their overall digital transformation,” said Mr. Campbell. “PTC customers are better leveraging existing investments in CAD, IoT, and digitalization of content through AR experiences, enabling people to visualize and interact with the digital world in the real-time context of their daily work.”

As a Titanium Sponsor of and exhibitor at the event, PTC is showcasing its latest AR solutions – Vuforia Studio, Vuforia Engine, and Vuforia Chalk – as well as distributing copies of the Aberdeen research report at booth 118. PTC is also participating in The International Symposium on Mixed and Augmented Reality (ISMAR) , which runs in conjunction with AWE Europe, in booth 405.

Adoption Under the Vuforia Brand
In line with the data and findings of the Aberdeen report, PTC has experienced substantial growth and adoption across its dedicated AR business unit. Over 60,000 commercial AR apps have been deployed with PTC’s Vuforia® Engine. In addition, more than 14,000 participants have joined PTC’s Vuforia Studio Free Trial program , providing valuable feedback on use case priorities and hardware requirements, and over 550,000 registered developers use Vuforia as their preferred platform to create AR apps.

PTC has leveraged Vuforia to expand the capabilities of its market-leading ThingWorx ® Industrial Innovation Platform, enabling customers to visualize, instruct, guide, and improve interactions with physical things. Aberdeen data released today shows that Internet of Things (IoT) technology is currently a function of 82 percent of all businesses leveraging AR.

Aberdeen Report: “How the Best-in-Class Use Augmented Reality for Superior Service Management”
The Aberdeen report, which investigates service AR use cases of best-in-class organizations versus all other adopters, offers the following highlights:

  • Service organizations using AR have performed significantly better than non-users across customer retention, customer satisfaction, and year-over-year revenue improvement
  • The best-in-class companies have performed, on average, 25 percent better than their peers across performance measurements, including regulatory and SLA compliance
  • 34 percent of best-in-class organizations leverage AR-powered training, 31 percent use on-site guides, and 25 percent are using AR-powered knowledge sharing

To download a copy of the full report, please visit https://www.ptc.com/en/AWE-Europe .

Additional Resources

The adoption by customers of Vuforia AR solutions to date is not indicative of the amount of revenue with respect to any particular period or that customers will continue to adopt or deploy such technologies at any particular rate.

About PTC (NASDAQ: PTC)
PTC helps companies around the world reinvent the way they design, manufacture, operate, and service products in and for a smart, connected world. In 1986 we revolutionized digital 3D design, and in 1998 were first to market with Internet-based product lifecycle management. Today, our leading industrial innovation platform and field-proven solutions enable you to unlock value at the convergence of the physical and digital worlds. With PTC, manufacturers and an ecosystem of partners and developers can capitalize on the promise of the Internet of Things and augmented reality technology today and drive the future of innovation.

PTC.com @PTC Blogs

PTC, Vuforia, ThingWorx, and the PTC logo are trademarks or registered trademarks of PTC Inc. and/or its subsidiaries in the United States and other countries.

Contact:

PTC Jack McAvoy, 781-370-6143 Corporate Communications jmcavoy@ptc.com

Link:

ClickThru

Social Media:

https://www.facebook.com/PTC.Inc

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Together AI and HUMAIN Form Strategic Partnership to Accelerate AI Infrastructure and Cloud Services in Saudi Arabia31.8.2026 14:00:00 CEST | Press release

The partnership, which was announced on stage at LEAP, Combines HUMAIN’s AI Infrastructure Foundation with Together’s AI Native Cloud Platform and Global Reach Together AI, a leading San Francisco-based AI Native Cloud platform, and HUMAIN, a PIF company delivering full-stack artificial intelligence capabilities globally, today at LEAP announced a strategic partnership to connect HUMAIN’s rapidly expanding AI compute capacity in Saudi Arabia with global AI-native and enterprise demand. The partnership will include the construction of a new 250 megawatt data center, located in Saudi Arabia. The partnership brings together HUMAIN’s large-scale, multi-chip AI infrastructure footprint, expanding cloud and inference capabilities with Together AI’s global customer ecosystem and AI-native inference platform. Together, the companies will offer an additional option for developers, enterprises, and AI-native organizations worldwide to access high-performance AI infrastructure for inference and t

SLB to Acquire Kelvion, Expanding its Role Across Data Center Infrastructure31.8.2026 12:50:00 CEST | Press release

Scalable, energy-efficient and reliable thermal management technologies will optimize operating performance in increasingly complex data centers and industrial systems SLB (NYSE: SLB) today announced it has signed an agreement to acquire Kelvion, a global provider of thermal management and heat exchange technologies. The acquisition strengthens SLB's Data Center Solutions business with critical thermal management technologies and expands the company's role in data center infrastructure, which is one of the world’s fastest-growing industrial and technology markets. “AI is driving the most significant infrastructure investment cycle in our lifetime,” said Olivier Le Peuch, chief executive officer of SLB. “This transaction accelerates our ambition to become an industrial technology partner to the data center industry and help customers address the growing infrastructure complexity required to scale AI. Kelvion advances our path toward more integrated data center infrastructure solutions,

BeOne Medicines Announces New Phase 3 Survival Data Reinforcing Benefit of ZIIHERA-Containing Regimens in First-Line HER2+ Gastroesophageal Cancer31.8.2026 12:00:00 CEST | Press release

Findings provide further evidence of overall survival benefit of TEVIMBRA plus ZIIHERA and chemotherapy regimen in HER2+ GEAZIIHERA plus chemotherapy demonstrated statistically significant overall survival benefit at second interim analysis of HERIZON-GEA-01 trial BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced positive topline results from the second interim analysis (IA2) of the Phase 3 HERIZON-GEA-01 trial evaluating ZIIHERA® (zanidatamab), in combination with chemotherapy, with and without TEVIMBRA® (tislelizumab), as first-line treatment for HER2+ locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). At IA2, ZIIHERA plus chemotherapy demonstrated a statistically significant and clinically meaningful improvement in overall survival (OS) compared with trastuzumab plus chemotherapy, meeting the remaining primary endpoint analysis of the study. IA2 also provided longer follow-up data for the TEVIMBRA plus ZIIHERA

GigaDevice Strengthens EMEA and Southeast Asia Market Reach Through Strategic Partnership with Rutronik31.8.2026 09:00:00 CEST | Press release

GigaDevice, a leading semiconductor company specializing in Flash memory, 32-bit microcontrollers (MCUs), sensors, and analog products, today announced a new strategic franchise partnership with Rutronik Elektronische Bauelemente GmbH, one of Europe’s leading broadline distributors of electronic components. The agreement covers EMEA and Southeast Asia, including India, and provides customers with broader access to GigaDevice’s comprehensive portfolio of microcontrollers, sensors, and power management solutions. The partnership further strengthens GigaDevice’s distribution network and local market presence across key regions. With its strong presence across Europe and growing coverage in Southeast Asia, Rutronik provides GigaDevice with an established channel supported by extensive market reach, technical expertise, and customer relationships. The collaboration will help expand access to GigaDevice’s embedded solutions across a broad range of applications and industries, including indus

Alnylam Presents New Data at ESC Congress 2026 Reinforcing Strength in RNAi-Powered TTR Silencing Across ATTR-CM Patient Populations and Treatment Settings30.8.2026 14:23:00 CEST | Press release

–Late-Breaking Prespecified Subgroup Analysis of HELIOS-B Demonstrates that Vutrisiran Provided Consistent Clinical Benefit Across All-Cause Mortality and Recurrent Cardiovascular Events in Patients With or Without Tafamidis Use at Baseline ––Additional Post Hoc Analyses Highlight Positive Impact of Vutrisiran in Addressing the Multisystemic Manifestations of ATTR-CM ––Pooled Analysis Across Four Positive Phase 3 Studies of Vutrisiran and Patisiran Shows Consistent Treatment Effect Across Sexes ––New Subgroup Analysis from KARDIA-3 Phase 2 Study of Zilebesiran Highlights Potential to Provide Enhanced Blood Pressure Control – Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, today announced new data at the European Society of Cardiology (ESC) Congress 2026 demonstrating the strength of RNAi-powered silencing for cardiovascular disease. The findings further reinforce the clinical profile of AMVUTTRA® (vutrisiran) across transthyretin amyloidosis (ATTR)

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye